Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design
- Authors
- Anderson JL
- Angiolillo DJ
- Antman EM
- Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators.
- Batchelor WB
- Bertrand ME
- Bovill EG
- Braunwald E
- Brodie BR
- Brodie BR
- Chan AW
- Chesebro JH
- Cutlip DE
- Danzi GB
- Danzi GB
- Danzi GB
- De Luca G
- Dong J
- Ellis SG
- Ernst NM
- Gabriel HM
- Gurbel PA
- Hochholzer W
- Kabbani SS
- Kastrati A
- Kastrati A
- Lee DP
- Liem AL
- McLaughlin MG
- Mehilli J
- Mehta SR
- Montalescot G
- Ndrepepa G
- Sabatine MS
- Sabatine MS
- Schneider DJ
- Schneider DJ
- Schroder K
- Schömig A
- Simes RJ
- Steinhubl SR
- Stenestrand U
- Stone GW
- The EPIC Investigation.
- The EPILOG Investigators.
- The EPISTENT Investigators.
- The TIMI Study Group.
- Thiele H
- Topol EJ
- Valgimigli M
- Van de Werf F
- van der Horst IC
- van ‘t Hof AWJ
- van ‘t Hof AWJ
- van ‘t Hof AWJ
- Yusuf S
- Zeymer U
- Zeymer U
- Zijlstra F
- Zijlstra F
- Zijlstra F
- Zorman S
- Publication date
- Publisher
- 'Europa Digital & Publishing'
- Doi